Prostate Cancer Drugs Market Report

Global and Region Prostate Cancer Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：154
  • REPORT CODE：GMM889173
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Prostate Cancer Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Prostate Cancer Drugsmarket, defines the market attractiveness level of Prostate Cancer Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Prostate Cancer Drugs industry, describes the types of Prostate Cancer Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Prostate Cancer Drugs market and the development prospects and opportunities of Prostate Cancer Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Prostate Cancer Drugs market in Chapter 13.

    By Player:

    • Foresee Pharmaceuticals

    • Merck Group

    • Teva Pharmaceutical

    • Johnson & Johnson

    • BMS

    • Bayer HealthCare

    • Sanofi

    • Tokai Pharmaceuticals

    • Northwest Biotherapeutics

    • Novartis

    • Ferring Pharmaceutical

    • AbbVie

    • Boehringer Ingelheim

    • Janssen Pharmaceuticals

    • Endo Pharmaceuticals

    • Astra Zeneca

    • GlaxoSmithKline

    • Amgen

    • Astellas Pharma

    • Spectrum Pharmaceuticals

    • Takeda Pharmaceuticals

    By Type:

    • Hormonal Therapy

    • Chemotherapy

    • Immunotherapy

    • Targeted Therapy

    By End-User:

    • Clinics

    • Hospitals

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Prostate Cancer Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Prostate Cancer Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Prostate Cancer Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Prostate Cancer Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Prostate Cancer Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Prostate Cancer Drugs Consumption (2017-2022)

    • 7.2 United States Prostate Cancer Drugs Consumption (2017-2022)

    • 7.3 Europe Prostate Cancer Drugs Consumption (2017-2022)

    • 7.4 China Prostate Cancer Drugs Consumption (2017-2022)

    • 7.5 Japan Prostate Cancer Drugs Consumption (2017-2022)

    • 7.6 India Prostate Cancer Drugs Consumption (2017-2022)

    • 7.7 South Korea Prostate Cancer Drugs Consumption (2017-2022)

    8 Region and Country-wise Prostate Cancer Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Prostate Cancer Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Prostate Cancer Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Prostate Cancer Drugs Consumption Forecast (2022-2028)

    • 8.4 China Prostate Cancer Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Prostate Cancer Drugs Consumption Forecast (2022-2028)

    • 8.6 India Prostate Cancer Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Prostate Cancer Drugs Consumption Forecast (2022-2028)

    9 Global Prostate Cancer Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Prostate Cancer Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Hormonal Therapy Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Immunotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Targeted Therapy Consumption and Growth Rate (2017-2022)

    • 9.2 Global Prostate Cancer Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Prostate Cancer Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Prostate Cancer Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Hormonal Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Prostate Cancer Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Prostate Cancer Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Prostate Cancer Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Prostate Cancer Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Prostate Cancer Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Prostate Cancer Drugs Market Competitive Analysis

    • 14.1 Foresee Pharmaceuticals

      • 14.1.1 Foresee Pharmaceuticals Company Details

      • 14.1.2 Foresee Pharmaceuticals Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Foresee Pharmaceuticals Prostate Cancer Drugs Product and Service

    • 14.2 Merck Group

      • 14.2.1 Merck Group Company Details

      • 14.2.2 Merck Group Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Merck Group Prostate Cancer Drugs Product and Service

    • 14.3 Teva Pharmaceutical

      • 14.3.1 Teva Pharmaceutical Company Details

      • 14.3.2 Teva Pharmaceutical Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Teva Pharmaceutical Prostate Cancer Drugs Product and Service

    • 14.4 Johnson & Johnson

      • 14.4.1 Johnson & Johnson Company Details

      • 14.4.2 Johnson & Johnson Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Johnson & Johnson Prostate Cancer Drugs Product and Service

    • 14.5 BMS

      • 14.5.1 BMS Company Details

      • 14.5.2 BMS Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 BMS Prostate Cancer Drugs Product and Service

    • 14.6 Bayer HealthCare

      • 14.6.1 Bayer HealthCare Company Details

      • 14.6.2 Bayer HealthCare Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Bayer HealthCare Prostate Cancer Drugs Product and Service

    • 14.7 Sanofi

      • 14.7.1 Sanofi Company Details

      • 14.7.2 Sanofi Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Sanofi Prostate Cancer Drugs Product and Service

    • 14.8 Tokai Pharmaceuticals

      • 14.8.1 Tokai Pharmaceuticals Company Details

      • 14.8.2 Tokai Pharmaceuticals Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Tokai Pharmaceuticals Prostate Cancer Drugs Product and Service

    • 14.9 Northwest Biotherapeutics

      • 14.9.1 Northwest Biotherapeutics Company Details

      • 14.9.2 Northwest Biotherapeutics Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Northwest Biotherapeutics Prostate Cancer Drugs Product and Service

    • 14.10 Novartis

      • 14.10.1 Novartis Company Details

      • 14.10.2 Novartis Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Novartis Prostate Cancer Drugs Product and Service

    • 14.11 Ferring Pharmaceutical

      • 14.11.1 Ferring Pharmaceutical Company Details

      • 14.11.2 Ferring Pharmaceutical Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Ferring Pharmaceutical Prostate Cancer Drugs Product and Service

    • 14.12 AbbVie

      • 14.12.1 AbbVie Company Details

      • 14.12.2 AbbVie Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 AbbVie Prostate Cancer Drugs Product and Service

    • 14.13 Boehringer Ingelheim

      • 14.13.1 Boehringer Ingelheim Company Details

      • 14.13.2 Boehringer Ingelheim Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Boehringer Ingelheim Prostate Cancer Drugs Product and Service

    • 14.14 Janssen Pharmaceuticals

      • 14.14.1 Janssen Pharmaceuticals Company Details

      • 14.14.2 Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Janssen Pharmaceuticals Prostate Cancer Drugs Product and Service

    • 14.15 Endo Pharmaceuticals

      • 14.15.1 Endo Pharmaceuticals Company Details

      • 14.15.2 Endo Pharmaceuticals Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Endo Pharmaceuticals Prostate Cancer Drugs Product and Service

    • 14.16 Astra Zeneca

      • 14.16.1 Astra Zeneca Company Details

      • 14.16.2 Astra Zeneca Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Astra Zeneca Prostate Cancer Drugs Product and Service

    • 14.17 GlaxoSmithKline

      • 14.17.1 GlaxoSmithKline Company Details

      • 14.17.2 GlaxoSmithKline Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 GlaxoSmithKline Prostate Cancer Drugs Product and Service

    • 14.18 Amgen

      • 14.18.1 Amgen Company Details

      • 14.18.2 Amgen Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Amgen Prostate Cancer Drugs Product and Service

    • 14.19 Astellas Pharma

      • 14.19.1 Astellas Pharma Company Details

      • 14.19.2 Astellas Pharma Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Astellas Pharma Prostate Cancer Drugs Product and Service

    • 14.20 Spectrum Pharmaceuticals

      • 14.20.1 Spectrum Pharmaceuticals Company Details

      • 14.20.2 Spectrum Pharmaceuticals Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Spectrum Pharmaceuticals Prostate Cancer Drugs Product and Service

    • 14.21 Takeda Pharmaceuticals

      • 14.21.1 Takeda Pharmaceuticals Company Details

      • 14.21.2 Takeda Pharmaceuticals Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 Takeda Pharmaceuticals Prostate Cancer Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Prostate Cancer Drugs

    • Figure Prostate Cancer Drugs Picture

    • Table Global Prostate Cancer Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Prostate Cancer Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Prostate Cancer Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Prostate Cancer Drugs Consumption by Country (2017-2022)

    • Figure United States Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Cancer Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hormonal Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Targeted Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Hormonal Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Prostate Cancer Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Prostate Cancer Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Foresee Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Foresee Pharmaceuticals Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Foresee Pharmaceuticals Prostate Cancer Drugs Product and Service

    • Table Merck Group (Foundation Year, Company Profile and etc.)

    • Table Merck Group Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Group Prostate Cancer Drugs Product and Service

    • Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Prostate Cancer Drugs Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Prostate Cancer Drugs Product and Service

    • Table BMS (Foundation Year, Company Profile and etc.)

    • Table BMS Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table BMS Prostate Cancer Drugs Product and Service

    • Table Bayer HealthCare (Foundation Year, Company Profile and etc.)

    • Table Bayer HealthCare Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer HealthCare Prostate Cancer Drugs Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Prostate Cancer Drugs Product and Service

    • Table Tokai Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Tokai Pharmaceuticals Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tokai Pharmaceuticals Prostate Cancer Drugs Product and Service

    • Table Northwest Biotherapeutics (Foundation Year, Company Profile and etc.)

    • Table Northwest Biotherapeutics Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Northwest Biotherapeutics Prostate Cancer Drugs Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Prostate Cancer Drugs Product and Service

    • Table Ferring Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Ferring Pharmaceutical Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ferring Pharmaceutical Prostate Cancer Drugs Product and Service

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Prostate Cancer Drugs Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Prostate Cancer Drugs Product and Service

    • Table Janssen Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Janssen Pharmaceuticals Prostate Cancer Drugs Product and Service

    • Table Endo Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Endo Pharmaceuticals Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Endo Pharmaceuticals Prostate Cancer Drugs Product and Service

    • Table Astra Zeneca (Foundation Year, Company Profile and etc.)

    • Table Astra Zeneca Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astra Zeneca Prostate Cancer Drugs Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Prostate Cancer Drugs Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Prostate Cancer Drugs Product and Service

    • Table Astellas Pharma (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Prostate Cancer Drugs Product and Service

    • Table Spectrum Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Spectrum Pharmaceuticals Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Spectrum Pharmaceuticals Prostate Cancer Drugs Product and Service

    • Table Takeda Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Takeda Pharmaceuticals Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Pharmaceuticals Prostate Cancer Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US